185 related articles for article (PubMed ID: 3112809)
1. Salicylate potentiates valproate-induced hyperammonemia in the rat.
Uetrecht JP
Pharmacology; 1987; 34(5):279-85. PubMed ID: 3112809
[TBL] [Abstract][Full Text] [Related]
2. Effects of 2,4-dinitrophenol on renal ammoniagenesis in the rat.
Imler M; Chabrier G; Marescaux C; Warter JM
Eur J Pharmacol; 1986 Apr; 123(2):175-9. PubMed ID: 3086107
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of salicylate against 2,4-dinitrophenol-induced protein thiol loss in the small intestine of rats.
Nishihata T; Suzuka T; Yata N; Sakai K
J Pharm Pharmacol; 1988 Jul; 40(7):516-8. PubMed ID: 2904997
[TBL] [Abstract][Full Text] [Related]
4. Sodium valproate-induced hyperammonemia in the rat: role of the kidney.
Warter JM; Imler M; Marescaux C; Chabrier G; Rumbach L; Micheletti G; Krieger J
Eur J Pharmacol; 1983 Feb; 87(2-3):177-82. PubMed ID: 6404641
[TBL] [Abstract][Full Text] [Related]
5. Valproate-induced hyperammonemia of renal origin. Effects of valproate on glutamine transport in rat kidney mitochondria.
Rumbach L; Cremel G; Marescaux C; Warter JM; Waksman A
Biochem Pharmacol; 1989 Nov; 38(22):3963-7. PubMed ID: 2512930
[TBL] [Abstract][Full Text] [Related]
6. Increase of valproate-induced hyperammonemia in normal subjects by carbohydrate intake.
Warter JM; Marescaux C; Chabrier G; Rumbach L; Micheletti G; Reitzer B; Hirsch E; Imler M
Neurology; 1984 Nov; 34(11):1487-9. PubMed ID: 6436732
[TBL] [Abstract][Full Text] [Related]
7. Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats.
Yu HY; Shen YZ; Sugiyama Y; Hanano M
Drug Metab Dispos; 1990; 18(1):121-6. PubMed ID: 1970771
[TBL] [Abstract][Full Text] [Related]
8. Hepatic ATP content and hyperammonemia induced by CCl4 in rats.
Yamamoto HA; Sugihara N
Toxicology; 1988 Sep; 51(1):111-7. PubMed ID: 3413798
[TBL] [Abstract][Full Text] [Related]
9. L-Arginine in the treatment of valproate overdose - five clinical cases.
Schrettl V; Felgenhauer N; Rabe C; Fernando M; Eyer F
Clin Toxicol (Phila); 2017 Apr; 55(4):260-266. PubMed ID: 28152637
[TBL] [Abstract][Full Text] [Related]
10. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome.
Trost LC; Lemasters JJ
Toxicol Appl Pharmacol; 1997 Dec; 147(2):431-41. PubMed ID: 9439738
[TBL] [Abstract][Full Text] [Related]
11. The renal origin of sodium valproate-induced hyperammonemia in fasting humans.
Warter JM; Brandt C; Marescaux C; Rumbach L; Micheletti G; Chabrier G; Krieger J; Imler M
Neurology; 1983 Sep; 33(9):1136-40. PubMed ID: 6412158
[TBL] [Abstract][Full Text] [Related]
12. Valproate use associated with persistent hyperammonemia and mitochondrial injury in a child with Down's syndrome.
Kane RE; Kotagel S; Bacon BR; Vogler CA
J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):223-7. PubMed ID: 1534366
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats.
Yue TL; Varma DR
Drug Metab Dispos; 1982; 10(2):147-52. PubMed ID: 6124400
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia in primary cultured rat hepatocytes.
Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
Biochem Pharmacol; 1988 Jun; 37(11):2255-8. PubMed ID: 3132174
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein binding interaction between valproic and salicylic acids in rhesus monkeys.
Viswanathan CT; Levy RH
J Pharm Sci; 1981 Nov; 70(11):1279-81. PubMed ID: 6795339
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of metabolic processes by coenzyme-A-sequestering aromatic acids. Prevention by para-chloro- and para-nitrobenzoic acids.
Swartzentruber MS; Harris RA
Biochem Pharmacol; 1987 Oct; 36(19):3147-53. PubMed ID: 3117062
[TBL] [Abstract][Full Text] [Related]
17. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by salicylates of urea synthesis by isolated rat hepatocytes and citrulline synthesis by isolated rat mitochondria: an effect independent of uncoupling.
Kay JD
Horm Metab Res; 1988 Jun; 20(6):333-5. PubMed ID: 3417218
[TBL] [Abstract][Full Text] [Related]
19. Hepatic and renal contributions to valproic acid-induced hyperammonemia.
Marini AM; Zaret BS; Beckner RR
Neurology; 1988 Mar; 38(3):365-71. PubMed ID: 3126407
[TBL] [Abstract][Full Text] [Related]
20. Hyperammonemia following intravenous valproate loading.
DeWolfe JL; Knowlton RC; Beasley MT; Cofield S; Faught E; Limdi NA
Epilepsy Res; 2009 Jul; 85(1):65-71. PubMed ID: 19299111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
